首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话15274084725)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话15274084725)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4464
Lilly del Caribe, Inc.
2003/11/26 0:00:00
TADALAFIL
DRUG FOR FURTHER PROCESSING
20
0110-4464_
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4465
Lilly del Caribe, Inc.
2008/1/7 0:00:00
TADALAFIL
DRUG FOR FURTHER PROCESSING
2.5
0110-4465_
Tadalafil
DRUG FOR FURTHER PROCESSING
0110-4467
Lilly del Caribe, Inc.
2009/5/22 0:00:00
TADALAFIL
DRUG FOR FURTHER PROCESSING
20
0110-4467_
baricitinib
DRUG FOR FURTHER PROCESSING
0110-4479
Lilly del Caribe, Inc.
2017/1/16 0:00:00
BARICITINI
DRUG FOR FURTHER PROCESSING
4
0110-4479_
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-4483
Lilly del Caribe, Inc.
2017/9/28 0:00:00
ABEMACICLI
DRUG FOR FURTHER PROCESSING
50
0110-4483_
lasmiditan
DRUG FOR FURTHER PROCESSING
0110-4491
Lilly del Caribe, Inc.
2019/10/11 0:00:00
LASMIDITAN
DRUG FOR FURTHER PROCESSING
100
0110-4491_
baricitinib
DRUG FOR FURTHER PROCESSING
0110-4732
Lilly del Caribe, Inc.
2019/1/10 0:00:00
BARICITINI
DRUG FOR FURTHER PROCESSING
1
0110-4732_
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-4815
Lilly del Caribe, Inc.
2017/9/28 0:00:00
ABEMACICLI
DRUG FOR FURTHER PROCESSING
100
0110-4815_
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-5337
Lilly del Caribe, Inc.
2017/9/28 0:00:00
ABEMACICLI
DRUG FOR FURTHER PROCESSING
150
0110-5337_
abemaciclib
DRUG FOR FURTHER PROCESSING
0110-6216
Lilly del Caribe, Inc.
2017/9/28 0:00:00
ABEMACICLI
DRUG FOR FURTHER PROCESSING
200
0110-6216_
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-9542
Lilly del Caribe, Inc.
2004/12/17 0:00:00
DULOXETINE
DRUG FOR FURTHER PROCESSING
60
0110-9542_
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-9543
Lilly del Caribe, Inc.
2004/12/17 0:00:00
DULOXETINE
DRUG FOR FURTHER PROCESSING
30
0110-9543_
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-9544
Lilly del Caribe, Inc.
2004/12/17 0:00:00
DULOXETINE
DRUG FOR FURTHER PROCESSING
20
0110-9544_
Duloxetine hydrochloride
DRUG FOR FURTHER PROCESSING
0110-9545
Lilly del Caribe, Inc.
2004/12/17 0:00:00
DULOXETINE
DRUG FOR FURTHER PROCESSING
40
0110-9545_
bismuth subsalicylate
DRUG FOR FURTHER PROCESSING
0113-3016
L. Perrigo Company
1991/4/15 0:00:00
BISMUTH SU
DRUG FOR FURTHER PROCESSING
262
0113-3016_
ibuprofen
DRUG FOR FURTHER PROCESSING
0113-4000
L. Perrigo Company
1988/1/15 0:00:00
IBUPROFEN
DRUG FOR FURTHER PROCESSING
200
0113-4000_
ibuprofen
DRUG FOR FURTHER PROCESSING
0113-4001
L. Perrigo Company
1988/6/15 0:00:00
IBUPROFEN
DRUG FOR FURTHER PROCESSING
200
0113-4001_
aspirin
DRUG FOR FURTHER PROCESSING
0113-4002
L. Perrigo Company
1987/7/15 0:00:00
ASPIRIN
DRUG FOR FURTHER PROCESSING
325
0113-4002_
ibuprofen
DRUG FOR FURTHER PROCESSING
0113-4003
L. Perrigo Company
2006/4/26 0:00:00
IBUPROFEN
DRUG FOR FURTHER PROCESSING
200
0113-4003_
acetaminophen
DRUG FOR FURTHER PROCESSING
0113-4004
L. Perrigo Company
2000/5/12 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
650
0113-4004_
首页
(current)
7
(current)
8
(current)
9
(current)
10
(current)
11
(current)
12
(current)
13
(current)
14
(current)
15
(current)
16
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: